» Articles » PMID: 35962826

Preparation, Characterization and Stability of Cross Linked Nitrilase Aggregates (nitrilase-CLEAs) for Hydroxylation of 2-chloroisonicotinonitrile to 2-chloroisonicotinic Acid

Overview
Date 2022 Aug 13
PMID 35962826
Authors
Affiliations
Soon will be listed here.
Abstract

Nitrilases capable of performing hydroxylation of 2-chloroisonicotinonitrile to 2-chloroisonicotinic acid were screened, and ES-NIT-102 was the best nitrilase for said biotransformation. Nitrilase was immobilized as cross linked enzyme aggregates (nitrilase-CLEAs) by fractional precipitation with iso-propanol, and cross linked with glutaraldehyde. The nitrilase-CLEAs prepared with optimized 35 mM glutaraldehyde for 120 min cross linking time had 82.36 ± 4.45% residual activity, and displayed type-II structural CLEAs formation as confirmed by particle size, SEM, FTIR, and SDS-PAGE analysis. Nitrilase-CLEAs had superior pH and temperature stability, showed a shift in optimal temperature by 5 °C, and retained nearly 1.5 to 1.7 folds activity over free nitrilase at 50 °C and 55 °C after more than 9 h incubation. Nitrilase-CLEAs showed reduced affinity and decreased conversion of substrate as indicated by slightly higher K values by 5.19% and reduced V by 17%. Furthermore, these nitrilase-CLEAs showed 98% conversion, 94.72 g/L product formation, and 83.30% recovery after 24 h when used for hydroxylation of 2-chloroisonicotinonitrile to 2-chloroisonicotinic acid. Nitrilase-CLEAs were catalytically active for 3 cycles showcasing 81% conversion, 75.53 g/L product formation and 66.42% yield. The recovered product was confirmed by HPLC, FTIR, LC-MS, and H NMR, and displayed > 99% purity.

Citing Articles

Nitrilase GiNIT from Efficiently Degrades Nitriles Derived from Rapeseed Meal Glucosinolate.

Li H, Liu M, Wang Y, Luo X, Feng J, Zhao S Int J Mol Sci. 2024; 25(22).

PMID: 39596056 PMC: 11594246. DOI: 10.3390/ijms252211986.

References
1.
Peters R, Althaus M, Diolez C, Rolland A, Manginot E, Veyrat M . Practical formal total syntheses of the homocamptothecin derivative and anticancer agent diflomotecan via asymmetric acetate aldol additions to pyridine ketone substrates. J Org Chem. 2006; 71(20):7583-95. DOI: 10.1021/jo060928v. View

2.
Fukunaga K, Uehara F, Aritomo K, Shoda A, Hiki S, Okuyama M . 2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors. Bioorg Med Chem Lett. 2013; 23(24):6933-7. DOI: 10.1016/j.bmcl.2013.09.020. View

3.
Haga Y, Sakamoto T, Shibata T, Nonoshita K, Ishikawa M, Suga T . Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist. Bioorg Med Chem. 2009; 17(19):6971-82. DOI: 10.1016/j.bmc.2009.08.019. View

4.
Schwender C, Sunday B, Herzig D . 11-Oxo-11H-pyrido[2,1-b]quinazoline-8-carboxylic acid, an orally active antiallergy agent. J Med Chem. 1979; 22(1):114-6. DOI: 10.1021/jm00187a026. View

5.
Shen J, Cai X, Liu Z, Zheng Y . Nitrilase: a promising biocatalyst in industrial applications for green chemistry. Crit Rev Biotechnol. 2020; 41(1):72-93. DOI: 10.1080/07388551.2020.1827367. View